Novo’s Next Big Obesity Bet Fails to Beat Eli Lilly — Investors React Fast
The battle for dominance in the booming weight-loss drug market just took another dramatic turn. Shares of Novo Nordisk plunged…
The battle for dominance in the booming weight-loss drug market just took another dramatic turn. Shares of Novo Nordisk plunged…